Advanced Oncology Article Search

Top Read Oncology Articles

Top Read since last login

1 American Medical Group Association's 2015 Medical Group Compensation and Productivity Survey reports average increase in physician compensation at 2.8 percent American Medical Group Association News, July 17, 2015

2 Fish consumption and risk of myeloma: a meta-analysis of epidemiological studies Cancer Causes and Control, July 13, 2015    Evidence Based Medicine

3 Prospective clinical utility study of the use of the 21-gene assay in adjuvant clinical decision making in women with estrogen receptor-positive early invasive breast cancer: Results from the SWITCH Study The Oncologist, July 3, 2015    Free full text

4 Effect of mammographic screening from age 40 years on breast cancer mortality in the UK Age trial at 17 years' follow-up: a randomised controlled trial The Lancet Oncology, July 24, 2015

5 Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial The Lancet Oncology, July 17, 2015

6 Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung (LUX-Lung 8): an open-label randomised controlled phase 3 trial The Lancet Oncology, July 7, 2015

7 Gefitinib plus chemotherapy versus placebo plus chemotherapy in EGFR-mutation-positive non-small-cell lung cancer after progression on first-line gefitinib (IMPRESS): a phase 3 randomised trial The Lancet Oncology, July 9, 2015

8 Venlafaxine in management of hot flashes in women with breast cancer: a systematic review and meta-analysis Breast Cancer Research and Treatment, June 29, 2015    Evidence Based Medicine    Review Article

9 Outcomes with and without axillary node dissection for node-positive lumpectomy and mastectomy patients The American Journal of Surgery, July 10, 2015

10 Adjuvant lymph-node field radiotherapy versus observation only in patients with melanoma at high risk of further lymph-node field relapse after lymphadenectomy (ANZMTG 01.02/TROG 02.01): 6-year follow-up of a phase 3, randomised controlled trial The Lancet Oncology, July 23, 2015